SpinaLogic: For Lumbar Spinal Fusion

  • Adjunct to lumbar fusion surgery
  • Works with both anterior and posterior approaches
  • Improves fusion rate by 49%

Stimulates Bone Growth To Accelerate Healing

  • Combined Magnetic Field Bone Stimulators
  • Safe, non-invasive, light-weight & comfortable - simple, one-button operation
  • Brief treatment time - only 30 minutes a day - boosts compliance
  • Precise placement & skin contact not required
  • Compliance monitor - monitors patient usage
  • Approved FDA Class III medical device - the most stringent category - no known adverse effects

Features

Padded Comfort

Padded belting increases patient comfort, is easy to secure; trim to accommodate a wide range of sizes.

Anatomical Cushioning

Integrated, contoured cushioning ensures comfort where the coil rests against the body/spine.

Contoured Fit

Moldable belt allows close fit; easily contours to the patient’s body.

High Quality Materials

Soft, breathable, medical-grade fabrics are improved; distinctive two-tone coloring

Ordering Information

Please fax your orders to: (716) 712-0882 or our toll free fax at: (866) 712-0882.

References

  • CMF, the only bone stimulating technology with an FDA approved mechanism of action, up-regulates synergistic growth factor signals, specifically, intracellular calcium, calmodulin & IGF II - all key factors in the formation of bone (Washinton State Health Technology Assessment of Bone Growth Stimulators, 2009).
  • A multi-center, randomized, double blind study of 201 patients undergoing posterolateral lumbar spinal fusion without instrumentation reported a 64% success rate with CMF stimulation, versus 43% without (Linovitz et al., Spine 27:1383-9).
  • Patients with Charcot foot neuroarthropathy who received CMF treatment were able to resume ambulation in less than half the time of controls (11.1 weeks versus 23.8), and often with less joint destruction and residual deformity (J Foot Ankle Surg.1998;37(6):510-5).
  • Sales of bone stimulators, particularly the noninvasive spinal fusion stimulators, are climbing rapidly (Frost and Sullivan Research Report on “U.S. Bone Growth and Spinal Fusion Stimulators Markets”).
  • A 2008 survey of orthopedic surgeons regarding treatment of complicated tibial fractures, found that almost half (45%) of those responding employed bone stimulators as part of their management strategy (ActaOrthop.2008;79(5):689-94).